Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Platelet Rich Plasma Combined With Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Patients With Stage 3 and 4 Stress Injury

NCT06302582 is registered in ClinicalTrials.gov with Liaocheng People's Hospital as lead sponsor.

NCT NCT06302582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06302582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Platelet Rich Plasma Combined With Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Patients With Stage 3 and 4 Stress Injury
Lead sponsor
Liaocheng People's Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
February 29, 2024
Completion date
November 25, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pressure injuries - stage 3, pressure injuries - stage 4